User profiles for Kasmintan A. Schrader

Kasmintan Schrader

BC Cancer, UBC
Verified email at bccancer.bc.ca
Cited by 5443

Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond

…, M Woo, J Senz, H Pinheiro, KA Schrader… - JAMA …, 2015 - jamanetwork.com
Importance E-cadherin (CDH1) is a cancer predisposition gene mutated in families meeting
clinically defined hereditary diffuse gastric cancer (HDGC). Reliable estimates of cancer risk …

A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia

S Shah, KA Schrader, E Waanders, AE Timms, J Vijai… - Nature …, 2013 - nature.com
Somatic alterations of the lymphoid transcription factor gene PAX5 (also known as BSAP) are
a hallmark of B cell precursor acute lymphoblastic leukemia (B-ALL) 1 , 2 , 3 , but inherited …

Germline variants in targeted tumor sequencing using matched normal DNA

KA Schrader, DT Cheng, V Joseph, M Prasad… - JAMA …, 2016 - jamanetwork.com
Importance Tumor genetic sequencing identifies potentially targetable genetic alterations
with therapeutic implications. Analysis has concentrated on detecting tumor-specific variants, …

[PDF][PDF] Point mutations in exon 1B of APC reveal gastric adenocarcinoma and proximal polyposis of the stomach as a familial adenomatous polyposis variant

…, PS Meltzer, DL Worthley, KA Schrader… - The American Journal of …, 2016 - cell.com
Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) is an autosomal-dominant
cancer-predisposition syndrome with a significant risk of gastric, but not colorectal, …

Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants

…, CS Yi, L Zhang, SE Plon, KA Schrader… - Human …, 2018 - Wiley Online Library
The variant curation guidelines published in 2015 by the American College of Medical Genetics
and Genomics and the Association for Molecular Pathology (ACMG/AMP) provided the …

Homologous recombination deficiency and platinum-based therapy outcomes in advanced breast cancer

…, K Gelmon, H Lim, D Renouf, S Sun, KA Schrader… - Clinical Cancer …, 2017 - AACR
Purpose: Recent studies have identified mutation signatures of homologous recombination
deficiency (HRD) in over 20% of breast cancers, as well as pancreatic, ovarian, and gastric …

[HTML][HTML] Cancer genomics and inherited risk

ZK Stadler, KA Schrader, J Vijai… - Journal of clinical …, 2014 - ncbi.nlm.nih.gov
Next-generation sequencing (NGS) has enabled whole-exome and whole-genome sequencing
of tumors for causative mutations, allowing for more accurate targeting of therapies. In …

Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategy

KA Schrader, J Hurlburt, SE Kalloger… - Obstetrics & …, 2012 - journals.lww.com
OBJECTIVE: To estimate the frequency of BRCA1 and BRCA2 germline mutations in women
with nonmucinous epithelial ovarian carcinoma unselected for a family history of breast or …

[HTML][HTML] The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk

…, T Thomas, A Maria, D Villano, KA Schrader… - NPJ breast …, 2017 - nature.com
Understanding the gene-specific risks for development of breast cancer will lead to improved
clinical care for those carrying germline mutations in cancer predisposition genes. We …

[HTML][HTML] A Recessive Founder Mutation in Regulator of Telomere Elongation Helicase 1, RTEL1, Underlies Severe Immunodeficiency and Features of Hoyeraal …

…, G Sarek, JB Vannier, T Stracker, KA Schrader… - PLoS …, 2013 - journals.plos.org
Dyskeratosis congenita (DC) is a heterogeneous inherited bone marrow failure and cancer
predisposition syndrome in which germline mutations in telomere biology genes account for …